EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis

Benoît Brilland iD, Charlotte Boud'hors, Samuel Wacrenier, Simon Blanchard, Jérôme Cayon, Odile Blanchet iD, Giorgina Barbara Piccoli, Nicolas Henry, Assia Djema, Jean-Philippe Coindre, Pascale Jeannin, Yves Delneste und 2 weitere

Clinical Kidney Journal · 31.08.2023 · 16 (9) · 1521-1533

DOI: 10.1093/ckj/sfad071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 03.04.2023. Verfasst von Benoît Brilland und 13 weiteren Autor:innen. Beteiligte Einrichtung: Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney injury molecule 1 (KIM-1) is a transmembrane glycoprotein expressed by proximal tubular cells, recognized as an early, sensitive and specific urinary biomarker for kidney injury. Blood KIM-1 was recently associated with the severity of acute and chronic kidney damage but its value in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis with glomerulonephritis (ANCA-GN) has not been studied. Thus, we analyzed its expression at ANCA-GN diagnosis and its relationship with clinical presentation, kidney histopathology and early outcomes.

Methods

We assessed KIM-1 levels and other pro-inflammatory molecules (C-reactive protein, interleukin-6, tumor necrosis factor α, monocyte chemoattractant protein-1 and pentraxin 3) at ANCA-GN diagnosis and after 6 months in patients included in the Maine-Anjou registry, which gathers data patients from four French Nephrology Centers diagnosed since January 2000.

Results

Blood KIM-1 levels were assessed in 54 patients. Levels were elevated at diagnosis and decreased after induction remission therapy. KIM-1 was associated with the severity of renal injury at diagnosis and the need for kidney replacement therapy. In opposition to other pro-inflammatory molecules, KIM-1 correlated with the amount of acute tubular necrosis and interstitial fibrosis/tubular atrophy (IF/TA) on kidney biopsy, but not with interstitial infiltrate or with glomerular involvement. In multivariable analysis, elevated KIM-1 predicted initial estimated glomerular filtration rate (β = –19, 95% CI –31, –7.6, P = .002).

Conclusion

KIM-1 appears as a potential biomarker for acute kidney injury and for tubulointerstitial injury in ANCA-GN. Whether KIM-1 is only a surrogate marker or is a key immune player in ANCA-GN pathogenesis remain to be determined.

Schlagwörter

Stichwörter der Autor:innen

ANCAKIM-1glomerulonephritistubulointerstitial injuryvasculitis

Autor:innen und Institutionen

  • Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France.
  • Univ. Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, Angers, France.
  • Service de Néphrologie, Centre Hospitalier du Mans, Le Mans, France.
  • Laboratoire d'Immunologie et d'Allergologie, CHU d'Angers, Angers, France.
  • Univ. Angers, SFR ICAT, PACeM (Plateforme d'Analyse Cellulaire et Moléculaire), Angers, France.
  • Centre de Ressources Biologiques, BB-0033-00038, CHU Angers, Angers, France.

ORCID-Profile: Benoît Brilland, Odile Blanchet, Jean-François Augusto

Zitieren

APA

Brilland, B., Boud'hors, C., Wacrenier, S., Blanchard, S., Cayon, J., Blanchet, O., Piccoli, G. B., Henry, N., Djema, A., Coindre, J. P., Jeannin, P., Delneste, Y., Copin, M. C., & Augusto, J. F. (2023). Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis. Clinical Kidney Journal, 16(9), 1521-1533. https://doi.org/10.1093/ckj/sfad071

Vancouver

Brilland B, Boud'hors C, Wacrenier S, Blanchard S, Cayon J, Blanchet O, et al. Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis. Clinical Kidney Journal. 2023;16(9):1521-1533. doi:10.1093/ckj/sfad071

BibTeX
@article{Brilland2023,
  author = {Brilland, Benoît and Boud'hors, Charlotte and Wacrenier, Samuel and Blanchard, Simon and Cayon, Jérôme and Blanchet, Odile and Piccoli, Giorgina Barbara and Henry, Nicolas and Djema, Assia and Coindre, Jean-Philippe and Jeannin, Pascale and Delneste, Yves and Copin, Marie-Christine and Augusto, Jean-François},
  title = {Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis},
  journal = {Clinical Kidney Journal},
  year = {2023},
  volume = {16},
  number = {9},
  pages = {1521--1533},
  doi = {10.1093/ckj/sfad071}
}
Kostenlos starten →